Paradigm shifts in cardiovascular medicine

Journal of the American College of Cardiology

Volumn 43, Issue 4, 2004, Pages 507-512

  Holmes Jr , David R ^a   Firth, Brian G ^b   Wood, Douglas L ^a  

^a MAYO CLINIC   (United States)

^b Department of Medical Affairs and Health Ecomomics Worldwide   (United States)

Author keywords

Arterial Revascularization Therapy Study; Coronary artery bypass graft surgery; Diagnosis related group; Food and Drug Administration; International Classification of Diseases Ninth Revision; Percutaneous coronary intervention

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSIS RELATED GROUP; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; ECONOMIC EVALUATION; ECONOMICS; EXPECTATION; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HOSPITAL COST; HOSPITAL MANAGEMENT; HUMAN; INTERMETHOD COMPARISON; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MALE; MEDICARE; METHODOLOGY; MULTICENTER STUDY; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT; RESTENOSIS; REVIEW; STENT; UNITED STATES;

EID: 1242317700     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.08.049     Document Type: Review

References (30)

1. Opinion page. Wall Street Journal 2003;Jan. 10:A-10.
2. Heart Disease and Stroke Statistics - 2003 Update. 2002;American Heart Association, Dallas, TX.
3. Jones R.H., Kesler K., Phillips H.R. III, et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg. 111:1996;1013-1025.
4. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol. 35:2000;1122-1129.
5. Detre K.M., Lombardero M.S., Brooks M.M., et al. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. N Engl J Med. 342:2000;989-997.
6. King S.B. III, Kosinski A.S., Guyton R.A., Lembo N.J., Weintraub W.S. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol. 35:2000;1116-1121.
7. Niles N.W., McGrath P.D., Malenka D., et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization results of a large regional prospective study . J Am Coll Cardiol. 37:2001;1008-1015.
8. Abizaid A., Costa M.A., Centemero M., et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients insights from the Arterial Revascularization Therapy Study (ARTS) trial . Circulation. 104:2001;533-538.
9. Centers for Medicare and Medicaid Services Data Compendium. Available at: http://www.cms.hhs.gov Accessed December 30, 2003.
10. van Dijk D., Keizer A.M., Diephuis J.C., Durand C., Vos L.J., Hijman R. Neurocognitive dysfunction after coronary artery bypass surgery a systematic review . J Thorac Cardiovasc Surg. 120:2000;632-639.
11. Andrew M.J., Baker R.A., Kneebone A.C., Knight J.L. Neuropsychological dysfunction after minimally invasive direct coronary artery bypass grafting. Ann Thorac Surg. 66:1998;1611-1617.
12. Detre K.M., Holmes D.R. Jr., Holubkov R., et al. Incidence and consequences of periprocedural occlusion the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry . Circulation. 82:1990;739-750.
13. Holmes D.R. Jr., Vlietstra R.E., Smith H.C., et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA) a report from the PTCA registry of the National Heart, Lung, and Blood Institute . Am J Cardiol. 53:1984;77C-81C.
14. Holmes D.R. Jr., Savage M., LaBlanche J.-M., et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 106:2002;1243-1250.
15. Anderson H.V., Shaw R.E., Brindis R.G., et al. A contemporary overview of percutaneous coronary interventions the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) . J Am Coll Cardiol. 39:2002;1096-1103.
16. Seshadri N., Whitlow P.L., Acharya N., Houghtaling P., Blackstone E.H., Ellis S.G. Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation. 106:2002;2346-2350.
17. Al Suwaidi J., Berger P.B., Holmes D.R. Jr. Coronary artery stents. JAMA. 284:2000;1828-1836.
18. Farb A., Sangiorgi G., Carter A.J., et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 99:1999;44-52.
19. Virmani R., Farb A. Pathology of in-stent restenosis. Curr Opin Lipidol. 10:1999;499-506.
20. Mintz G.S., Popma J.J., Hong M.K., et al. Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis. Am J Cardiol. 78:1996;18-22.
21. Mehran R., Dangas G., Abizaid A.S., et al. Angiographic patterns of in-stent restenosis classification and implications for long-term outcome . Circulation. 100:1999;1872-1878.
22. Serruys P.W., Unger F., Sousa J.E., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 344:2001;1117-1124.
23. Rodriguez A., Bernardi V., Navia J., et al. Argentine randomized study - Coronary Angioplasty with Stenting Versus Coronary Bypass Surgery in Patients with Multiple-Vessel Disease (ERACI II) 30-day and one-year follow-up results . J Am Coll Cardiol. 37:2001;51-58.
24. Stables R.H. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial) a randomised controlled trial . Lancet. 360:2002;965-970.
25. Leon M.B., Teirstein P.S., Moses J.W., et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 344:2001;250-256.
26. Popma J.J. Late clinical and angiographic outcomes after use of 90Sr/90Y beta radiation for the treatment of in-stent restenosis results from the 90Sr Treatment of Angiographic Restenosis Trial (START) . J Am Coll Cardiol. 36:2000;310-325.
27. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 346:2002;1773-1780.
28. Regar E., Serruys P.W., Bode C., et al. Angiographic findings of the multicenter Randomized Study with the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL) sirolimus-eluting stents inhibit restenosis irrespective of the vessel size . Circulation. 106:2002;1949-1956.
29. Serruys P.W., Degertekin M., Tanabe K., et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation. 106:2002;798-803.
30. Leon MB, Moses JW, Popma JJ, Kuntz RE, Fitzgerald P, for the SIRIUS Investigators. SIRIUS: a U.S., multicenter, randomized, double blind study of the sirolimus-eluting stent in de novo native coronary lesions. N Engl J Med 2003;349:1315-23.